Human trials of made-in-Vietnam Covid-19 vaccine to begin this week
Nanogen Company’s vaccine will the first to reach the stage of human trials in Vietnam.
Nanogen Company and the Military Medical Academy of Vietnam will officially recruit volunteers for first phase of human trials of made-in-Vietnam Covid-19 vaccine as early as this December.
Minister of Health Nguyen Thanh Long made the statement at a meeting in Hanoi on December 5 to report the progress of research and production of Covid-19 vaccine in the country.
Minister of Health Nguyen Thanh Long presided over the meeting to report on research and production of made-in-Vietnam Covid-19 vaccine. Photo: Kinhtedothi.vn
Nanogen is one of the four Vietnamese entities, including Vabiotech, Polyvac and the Institute of Vaccines and Medical Biologicals (IVAC), are researching Covid-19 vaccines. Nanogen’s vaccine will be the first to reach the stage of human trials.
Emphasizing the role and importance of research and production of Covid-19 vaccine, Minister Long said that the ministry had proactively promoted the vaccine study and manufacture activities in the country.
He also asked Vietnam’s vaccine production companies to speed up the progress to soon conduct clinical trials. Accordingly, on December 10, Nanogen in collaboration with the Military Medical Academy will officially carry out the first phase of human trials of made-in-Vietnam Covid-19 vaccine.
“Stakeholders need to immediately prepare for the second phase of clinical trial. We need to be proactive to get the vaccine as soon as possible," said Minister Nguyen Thanh Long.
He added that the Ministry of Health will provide all possible support to shorten all stages for vaccine production units such as streamlining administrative procedures, expediting registration, and licensing product.
The health ministry will report the Prime Minister on the investment policy for vaccine production and will coordinate with relevant agencies to assist them in accessing capital for the vaccine research and production, the minister noted.
Mr. Long asked Polyvac to continue developing Covid-19 vaccine and working closely with with partners, including those from China and Russia, on vaccine manufacturing.
Some 187 companies around the world are developing Covid-19 vaccines, of which 38 are being tested on humans. Vietnam’s health ministry and scientists are hoping to have a commercially-viable Covid-19 vaccine in the fourth quarter of 2021.
Vietnam has also registered to receive priority access to a Covid-19 vaccine when it is available on the market. However, it is not easy to buy Covid-19 vaccines because the demand far exceeds the production capacity. Governments that want to buy the vaccines must make a down payment.
- Hanoi hospitals to ensure quality healthcare during Tet
- Vietnamese doctors master single-port endoscopy
- EU Green Education: Significant to biodiversity protection in Vietnam
- Health sector joins efforts against climate change
- Treatment abroad no longer necessary for Vietnamese heart patients: Minister of Health
- Hanoi to host ASEAN Cardiology Congress 2023
- WHO praises Vietnam’s public health achievement
- Hanoi multiplies model of high-quality traditional medicine clinics
- Hanoi hospitals adjust service charges, remain confused about new pricing rule
- Hanoi to complete four major hospitals at gateways by 2025
Hanoi launches Reading Cultural Ambassador Contest
Vietnam news in brief - February 20
Hanoi encourages firms to sell to foreign distribution networks
Vietnam joins mega multinational naval exercise
National status for Hanoi's intangible heritage
Pen-brush opening ceremony: Vietnam's tradition honors learning
Site clearance is key for 500kV power line
Vietnam news in brief - February 17
Hanoi's Saint Giong Festival underway